Literature DB >> 13677407

Capacity building for an integrated noncommunicable disease risk factor surveillance system in developing countries.

Timothy Armstrong1, Ruth Bonita.   

Abstract

For the first time, the World Health Organization (WHO) is recommending that countries implement noncommunicable disease (NCD) surveillance by focusing on the major risk factors that predict the most common NCDs. To achieve this goal, member states are being offered a surveillance framework that provides a first step toward an integrated approach to NCD prevention and control. The goal of this framework, the STEPwise approach to NCD surveillance (STEPS), is to increase and sustain a country's capacity to ensure ongoing surveillance. Using the data to develop interventions and policies is an integral part of the STEPS approach, which, in turn, increases capacity to influence policy. Ongoing support from donors is essential to meeting the goal of increasing a country's capacity to undertake the NCD surveillance activity required to provide the basic information from which to formulate policy that effectively reduces the burden of disease.

Mesh:

Year:  2003        PMID: 13677407

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  17 in total

1.  High prevalence, low awareness, treatment and control rates of hypertension in Guinea: results from a population-based STEPS survey.

Authors:  A Camara; N M Baldé; M Diakité; D Sylla; E H Baldé; A P Kengne; M D Baldé
Journal:  J Hum Hypertens       Date:  2015-08-27       Impact factor: 3.012

2.  Mapping a global agenda for adolescent health.

Authors:  George C Patton; Russell M Viner; Le Cu Linh; Shanthi Ameratunga; Adesegun O Fatusi; B Jane Ferguson; Vikram Patel
Journal:  J Adolesc Health       Date:  2010-11       Impact factor: 5.012

3.  Prevalence and determinations of physical inactivity among public hospital employees in Shanghai, China: a cross-sectional study.

Authors:  Xinjian Li; Minna Cheng; Hao Zhang; Ting Ke; Yisheng Chen
Journal:  Front Med       Date:  2014-12-11       Impact factor: 4.592

4.  Guest Editorial: Strengthening NCD prevention through risk factor surveillance.

Authors:  Ruth Bonita
Journal:  Glob Health Action       Date:  2009-09-28       Impact factor: 2.640

5.  Using the INDEPTH HDSS to build capacity for chronic non-communicable disease risk factor surveillance in low and middle-income countries.

Authors:  Nawi Ng; Hoang Van Minh; Sanjay Juvekar; Abdur Razzaque; Tran Huu Bich; Uraiwan Kanungsukkasem; Ali Ashraf; Syed Masud Ahmed; Kusol Soonthornthada
Journal:  Glob Health Action       Date:  2009-09-28       Impact factor: 2.640

6.  Self-reported use of tobacco products in nine rural INDEPTH Health and Demographic Surveillance Systems in Asia.

Authors:  Ali Ashraf; M A Quaiyum; Nawi Ng; Hoang Van Minh; Abdur Razzaque; Syed Masud Ahmed; Abdullahel Hadi; Sanjay Juvekar; Uraiwan Kanungsukkasem; Kusol Soonthornthada; Tran Huu Bich
Journal:  Glob Health Action       Date:  2009-09-28       Impact factor: 2.640

7.  The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities.

Authors:  Leanne Riley; Regina Guthold; Melanie Cowan; Stefan Savin; Lubna Bhatti; Timothy Armstrong; Ruth Bonita
Journal:  Am J Public Health       Date:  2016-01       Impact factor: 9.308

8.  A surveillance sector review applied to infectious diseases at a country level.

Authors:  Michael G Baker; Sally Easther; Nick Wilson
Journal:  BMC Public Health       Date:  2010-06-11       Impact factor: 3.295

9.  Non-response bias in physical activity trend estimates.

Authors:  Cora L Craig; Christine Cameron; Joe Griffiths; Adrian Bauman; Catrine Tudor-Locke; Ross E Andersen
Journal:  BMC Public Health       Date:  2009-11-22       Impact factor: 3.295

10.  Economic aspects of chronic diseases in Vietnam.

Authors:  Hoang Van Minh; Dao Lan Huong; Kim Bao Giang; Peter Byass
Journal:  Glob Health Action       Date:  2009-12-20       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.